Balancing the Benefit and Risk of Oral Antiplatelet Agents in Coronary Artery Bypass Surgery

This publication has 82 references indexed in Scilit:

• A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation
  American Heart Journal, 2004
• Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery
  European Journal of Cardio-Thoracic Surgery, 2004
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Aprotinin
  Drugs, 1999
• Aprotinin counterbalances an increased risk of peri-operative haemorrhage in CABG patients pre-treated with Aspirin
  European Journal of Cardio-Thoracic Surgery, 1998
• Aspirin use and survival after coronary bypass surgery
  American Heart Journal, 1992
• Preoperative Aspirin Ingestion Increases Operative Blood Loss after Coronary Artery Bypass Grafting
  The Annals of Thoracic Surgery, 1988
• Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
  Circulation, 1985
• Effect of Ticlopidine on Saphenous Vein Bypass Patency Rates: A Double-blind Study
  The Annals of Thoracic Surgery, 1984
• Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations
  New England Journal of Medicine, 1984